Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rettig

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Leukemia|November 1, 1995
A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primersJ Cao, R A Vescio, M B Rettig, et al.
The Journal of Biological Chemistry|October 25, 2003
AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expressionJoseph F Gera, Ingo K Mellinghoff, Yijiang Shi, et al.
Clinical Nuclear Medicine|February 22, 2019
Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CTDavid J Lubin, Stuart B Holden, Matthew B Rettig, et al.
Prostate Cancer and Prostatic Diseases|March 25, 2023
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern eraTing Martin Ma, Felix Y Feng, Seth A Rosenthal, et al.
EJNMMI Research|October 30, 2023
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging studyIda Sonni, Andrei Gafita, Lena M Unterrainer, et al.
Scientific Reports|January 31, 2020
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumorQiongyu Hao, Tanya Diaz, Alejandro Del Rio Verduzco, et al.
Frontiers in Immunology|November 3, 2023
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancerHenning Zelba, Armin Rabsteyn, Oliver Bartsch, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRTNathanael Kane, Tahmineh Romero, Silvia Diaz-Perez, et al.
Current Treatment Options in Oncology|January 25, 2024
Impact of PSMA PET on Prostate Cancer ManagementAdam B Weiner, Raag Agrawal, Luca F Valle, et al.
Blood|September 9, 2000
Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myelomaD V Ablashi, L Chatlynne, D Thomas, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Leukemia|November 1, 1995
A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primersJ Cao, R A Vescio, M B Rettig, et al.
The Journal of Biological Chemistry|October 25, 2003
AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expressionJoseph F Gera, Ingo K Mellinghoff, Yijiang Shi, et al.
Clinical Nuclear Medicine|February 22, 2019
Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CTDavid J Lubin, Stuart B Holden, Matthew B Rettig, et al.
Prostate Cancer and Prostatic Diseases|March 25, 2023
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern eraTing Martin Ma, Felix Y Feng, Seth A Rosenthal, et al.
EJNMMI Research|October 30, 2023
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging studyIda Sonni, Andrei Gafita, Lena M Unterrainer, et al.
Scientific Reports|January 31, 2020
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumorQiongyu Hao, Tanya Diaz, Alejandro Del Rio Verduzco, et al.
Frontiers in Immunology|November 3, 2023
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancerHenning Zelba, Armin Rabsteyn, Oliver Bartsch, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRTNathanael Kane, Tahmineh Romero, Silvia Diaz-Perez, et al.
Current Treatment Options in Oncology|January 25, 2024
Impact of PSMA PET on Prostate Cancer ManagementAdam B Weiner, Raag Agrawal, Luca F Valle, et al.
Blood|September 9, 2000
Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myelomaD V Ablashi, L Chatlynne, D Thomas, et al.
Pageof 15